MASAKI Yasufumi

Researcher Profile & Settings

Research

Overview of research:
1, Clinical study of TAFRO syndrome 2, Clinical study of IgG4-related disease . 3, Early diagnosis and treatment of intravascular large B-cell lymphoma

Special Field

• Hematology
• Immunology

Degree

• Ph.D in Medicine

Academic & Professional Experience

• 1991- 1999Kanazawa Medical University,Hematology and Immunology Research Associate
• Jan. 1995- Dec. 1996The Scripps Research Institute Research Fellow
• 1999- Mar. 2007Kanazawa Medical University,Hematology and Immunology Instructor

Research Activities

Published Papers

• Interleukin-6-producing Intravascular Large B-cell Lymphoma with Lymphadenopathy Mimicking the Histology of Multicentric Castleman Disease, Kohei Shiroshita, Taku Kikuchi, Mikio Okayama, Hidenori Kasahara, Takahiro Kamiya, Takayuki Shimizu, Nozomu Kurose, Yasufumi Masaki, Shinichiro Okamoto, Internal Medicine, 59:3061-3065, Dec. 2020
• Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD, Takuji Nakamura, Tomomi Satoh-Nakamura, Akio Nakajima, Takafumi Kawanami, Tomoyuki Sakai, Yoshimasa Fujita, Haruka Iwao, Miyuki Miki, Yasufumi Masaki, Toshiro Okazaki, Yasuhito Ishigaki, Mitsuhiro Kawano, Kazunori Yamada, Shoko Matsui, Takako Saeki, Terumi Kamisawa, Motohisa Yamamoto, Hideaki Hamano, Tomoki Origuchi, Shintaro Hirata, Yoshiya Tanaka, Hiroto Tsuboi, Takayuki Sumida, Kazuichi Okazaki, Masao Tanaka, Tsutomu Chiba, Tsuneo Mimori, Hisanori Umehara, Modern Rheumatology, 30:551-557, May 2020
• 2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome, Yasufumi Masaki, Hiroshi Kawabata, Kazue Takai, Norifumi Tsukamoto, Shino Fujimoto, Yasuhito Ishigaki, Nozomu Kurose, Katsuhiro Miura, Shigeo Nakamura, Sadao Aoki, Japanese TAFRO Syndrome Research Team, International Journal of Hematology, 111:155-158, Jan. 2020
• The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease, (Zachary S Wallace), Ray P Naden, Suresh Chari, Hyon K Choi, Emanuel Della-Torre, Jean-Francois Dicaire, Phillip A Hart, Dai Inoue, Mitsuhiro Kawano, Arezou Khosroshahi, Marco Lanzillotta, Kazuichi Okazaki, Cory A Perugino, Amita Sharma, Takako Saeki, Nicolas Schleinitz, Naoki Takahashi, Hisanori Umehara, Yoh Zen, John H Stone, Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group, Annals of the Rheumatic Diseases, 79:77-87, Jan. 2020
• The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease, (Zachary S Wallace), Ray P Naden, Suresh Chari, Hyon Choi, Emanuel Della-Torre, Jean-Francois Dicaire, Phil A Hart, Dai Inoue, Mitsuhiro Kawano, Arezou Khosroshahi, Kensuke Kubota, Marco Lanzillotta, Kazuichi Okazaki, Cory A Perugino, Amita Sharma, Takako Saeki, Hiroshi Sekiguchi, Nicolas Schleinitz, James R Stone, Naoki Takahashi, Hisanori Umehara, George Webster, Yoh Zen, John H Stone, American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group, Arthritis & Rheumatology, 72:7-19, Jan. 2020
• Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagonosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial, (Kazuyuki Shimada), Motoko Yamaguchi, Yoshiko Atsuta, Kosei Matsue, Keijiro Sato, Shigeru Kusumoto, Hirokazu Nagai, Jun Takizawa, Noriko Fukuhara, Koji Nagafuji, Kana Miyazaki, Eiichi Ohtsuka, Masataka Okamoto, Yasumasa Sugita, Toshiki Uchida, Satoshi Kayukawa, Atsushi Wake, Daisuke Ennishi, Yukio Kondo, Tohru Izumi, Yoshihiro Kin, Kunihiro Tsukasaki, Daigo Hashimoto, Masaaki Yuge, Atsumi Yanagisawa, Yachiyo Kuwatsuka, Satoko Shimada, Yasufumi Masaki, Nozomi Niitsu, Hitoshi Kiyoi, Ritsuro Suzuki, Takashi Tokunaga, Shigeo Nakamura, Tomohiro Kinoshita, Lancet Oncology, 21:593-602, Apr. 2020
• An extranodal histopathological analysis of idiopathic multicentric Castleman disease with and without TAFRO syndrome, Kurose Nozomu, Mizutani Ken-Ichi, Kumagai Motona, Shioya Akihiro, Guo Xin, Nakada Satoko, Fujimoto Shino, Kawabata Hiroshi, Masaki Yasufumi, Takai Kazue, Aoki Sadao, Kojima Masaru, Nakamura Shigeo, Kida Masatoshi, Yamada Sohsuke, PATHOLOGY RESEARCH AND PRACTICE, 215:410-413, Mar. 2019
• A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease, Yasufumi.Masaki, shoko.Matsui, Takako.Saeki, Hiroto.Tsuboi, Shintaro.Hirata, Yasumori.Izumi, Taiichiro.Miyashita, Keita.Fujikawa, Hiroaki.Dobashi, Kentaro.Susaki, Hisanori.Morimoto, Kasutaka.Takagi, Mitsuhiro.Kawano,Tomoki.Origuchi, Yoko.Wada, Naoki.Takahashi, Masanobu.Horikashi, Hiroshi.Ogishima, Yasunori.Suzuki, Takafumi.Kawanami, Haruka.Kawanami Iwao, Tomoyuki.Sakai, Yoshimasa.Fujita, Toshihiro.Fukushima, Masatoshi.Saito, Ritsuro.Suzuki, Yuko.Morikawa, Tadashi.Yoshino, Shigeo.Nakamura, Masaru.Kojima, Nozomu.Kurose, Yasuharu.Sato, Yoshiya.Tanaka, Susumu.Sugai, Takayuki.Sumida, Modern Rheumatology, 27:849-854, May 2017
• Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts, (Zachary S Wallace), Yuqing Zhang, Cory A Perugino, Ray Naden, Hyon K Choi, John H Stone, for the ACR/EULAR IgG4-RD Classification Criteria Committee, Annals of the Rheumatic Diseases, 78:406-412, Mar. 2019
• Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases, (Sato Shuku), Teshima Shinichi, Nakamura Naoya, Ohtake Takayasu, Kikuchi Jun, Kishi Hirohisa, Nomura Kyoichi, Kurose Nozomu, Masaki Yasufumi, Tamaru Jun-Ichi, Pathology international, 69:97-103, Feb. 2019
  DOI:10.1111/pin.12751
• The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome, Kurose Nozomu, Guo Xin, Shioya Akihiro, Mizutani Ken-Ichi, Kumagai Motona, Fujimoto Shino, Kawabata Hiroshi, Masaki Yasufumi, Takai Kazue, Aoki Sadao, Nakamura Shigeo, Yamada Sohsuke, Pathology, research and practice, 215:152563, Oct. 2019
  DOI:10.1016/j.prp.2019.152563
• Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Mariko Doai, Munetaka Matoba, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Hiroki Mizumaki, Masaki Yamaguchi, Yasufumi Masaki, Internal Medicine, 58:2555-2560, Sep. 2019
• Retrospective survey of tumor lysis syndrome and acute uric acid nephropathy associated with cancer chemotherapy, (Kana Oiwa), Takahiro Yamauchi, Hitoshi Inoue, Hiromichi Iwasaki, Mikio Ueda, Yoshimasa Urasaki, Shigeki Otake, Hirokazu Okumura, Hideki Origasa, Kenichi Kamiya, Yasukazu Kawai, Shinji Kishi, Toshiro Kurokawa, Tsutomu Sato, Aiko Sawazaki, Hideyuki Takamatsu, Hiroshi Tsutani, Yasushi Terasaki, Shinji Nakao, Takashi Nakayama, Toshihiro Haba, Naoko Hosono, Yasufumi Masaki, Sadaya Matano, Ryoichi Murata, Masaki Yamaguchi, Nobuyuki Yoshio, Tatsuo Hosoya, Takanori Ueda, Gout and Uric & Nucleic Acids, 43:19-26, Jul. 2019
• Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan, Yasufumi Masaki, Hiroshi Kawabata, Shino Fujimoto, Mitsuhiro Kawano, Noriko Iwaki, Takeharu Kotani, Akikatsu Nakashima, Nozomu Kurose, Kazue Takai, Ritsuro Suzuki, Sadao Aoki, Journal of clinical and experimental hematopathology, 59:175-178, Dec. 2019
• Improved prognosis of extranodal NK/T cell lymphoma, nasal type of nasal origin but not extranasal origin, (Motoko Yamaguchi), Ritsuro Suzuki, Kana Miyazaki, Jun Amaki, Jun Takizawa, Nodoka Sekiguchi, Shiori Kinoshita, Naoto Tomita, Hideho Wada, Yukio Kobayashi, Nozomi Niitsu, Toshihiko Ando, Takeshi Maeda, Bungo Saito, Hiroshi Matsuoka, Rika Sakai, Nobuko Kubota, Yasufumi Masaki, Yoshihiro Kameoka, Naoko Asano, Masahiko Oguchi, Naoyuki Katayama, Annals of Hematology, 98:1647-1655, Jul. 2019
• Is TAFRO syndrome a subtype of idiopathic multicentric Castleman disease?, Shino Fujimoto, Tomoyuki Sakai, Hiroshi Kawabata, Nozomu Kurose, Sohsuke Yamada, Kazue Takai, Sadao Aoki, Junya Kuroda, Makoto Ide, Keigo Setoguchi, Norifumi Tsukamoto, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, American Journal of Hematology, 94:975-983, Sep. 2019
• The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome., Nozomu Kurose, Chizuru Futatsuya, Ken-Ichi Mizutani, Motona Kumagai, Akihiro Shioya, Xin Guo, Akane Aikawa, Satoko Nakada, Shino Fujimoto, Hiroshi Kawabata, Yasufumi Masaki, Kazue Takai, Sadao Aoki, Masaru Kojima, Shigeo Nakamura, Sohsuke Yamada, Human pathology, 77:130-138, Jul. 2018
  DOI:10.1016/j.humpath.2018.04.001
• Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome, Hanako Tsurumi, Yoshihide Fujigaki, Tadashi Yamamoto, Risa Iino, Kei Taniguchi, Michito Nagura, Shigeyuki Arai, Yoshifuru Tamura, Tatsuru Ota, Shigeru Shibata, Fukuo Kondo, Nozomu Kurose, Yasufumi Masaki,Shunya Uchida, Internal medicine, 57:1433-1438, May 2018
• Activities of the Ishikawa prefectural joint committee of blood transfusion therapy - Appropropriate use of albumin products, educational activities and role of pharmacists-, (Naohiro.Sugita), Hiroshi.Tanaka, Hidehiro.Satou, Toshihiko.Hutaki, Makiko.Miyamoto, Sinitiro.Yoneda, Aya.Okamoto, Yo.Taniguchi, Ikue.Yamasita, Makoto.Nitta, Masaki.Komori, Shintaro.Shiobara, Shuichi.Kikuchi, Akiyoshi.Takami, Hirohito.Yamazaki, Yasufumi.Masaki, Japanese Journal of Social Pharmacy, 37:2-8, Jun. 2018
• Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry., Caroline H Shiboski, Alan N Baer, Stephen C Shiboski, Mi Lam, Stephen Challacombe, FDSRCS, FRCPath, FMedSci, Hector E Lanfranchi, Morten Schiødt, Penelope Shirlaw, Muthiah Srinivasan, Hisanori Umehara, Frederick B Vivino, Esen Akpek, Vatinee Bunya, Cristina F Vollenweider, John S Greenspan, Troy E Daniels, Lindsey A Criswell, and for the Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups, Arthritis care & research., 70:284-294, Feb. 2018
• The standard international prognositc index for prediciting the risk of CNS involvement in DLBCL without specific prophylaxis, (Naoto.Tomita), Masahiro.Yokoyama, Wataru.Yamamoto, Reina.Watanabe, Yutaka.Shimazu, Yasufumi.Masaki, Saburo.Tsunoda, Chizuko.Hashimoto, Kayoko.Murayama, Takahiro.Yano, Rumiko.Okamoto, Ako.Kikuchi, Kazuo.Tamura, Kazuya.Sato, Kazutaka.Sunami, Hirohiko.Shibayama, Rishu.Takimoto, Rika.Ohshima, Hiromichi.Takahashi, Yukiyoshi.Moriuchi, Tomohiro.Kinoshita, Masahide.Yamamoto, Ayumi.Numata,HIdeaki.Nakajima, Ikuo.Miura, Kengo.Takeuchi, Leukemia & Lymphoma, 59:97-104, 2018
• Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan, Shino.Fujimoto, Tomohiro.Koga, Atsushi.Kawakami, Hiroshi.Kawabata, Shinichiro.Okamoto, Masao.Mizuki, Shingo.Yano, Makoto.Ide, Kazuko.Uno, Katsumi.Yagi, Toshiyuki.Kojima, Minoru.Mizutani, Yukihiro.Tokumine, Norihiro.Nishimoto, Hiroshi.Fujiwara, Shin-ichi.Nakatsuka, Kazuko.Shiozawa, Noriko.Iwaki, Yasufumi.Masaki, Kazuyuki.Yoshizaki, Modern Rheumatology, 28:161-167, Jan. 2018
• Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma, (Shinsuke.Iida), Masashi.Wakabayashi, Kunihiro.Tsukasaki, Kenichi.Miyamoto, Dai.Maruyama, Kazuhito.Yamamoto, Yoshifusa.Takatsuka, Shigeru.Kusumoto, Junya.Kuroda, Kiyoshi.Ando, Yoshitaka.Kikukuwa, Yasufumi.Masaki, Miki.Kobayashi, Ichiro.Hanamura, Hiroaki.Asai, Hirokazu.Nagai, Kazuyuki.Shimada, Norifumi.Tsukamoto, Yoshiko.Inoue, Kensei.Tobinai, Cancer Science, 109:1552-1561, 2018
• Human recombinant Fab fragment from combinatorial libraries of a B-cell lymphoma patient recognizes core protein of chondroitin sulphate proteoglycan 4, (Yoko.Egami), Yuta.Narushima, Motohiro.Ohshima, Akira.Yoshida, Naruki.Yoneta, Yasufumi.Masaki, Kunihiko.Itoh, The Journal of Biochemistry, 163:61-68, Jan. 2018
• The treatment strategy of IgG4-related disease - from the result of prospective clinical study -, Yasufumi.Masaki, Shino.Fujimoto, Haruka.Kawanami (Iwao), Tomoyuki.Sakai, Takafumi.Kawanami, Yopshimasa.Fujita, Hiroshi.Kawabata, Toshihiro.Fukushima, 29:140-146, Jun. 2017
• Therapeutic outlook for Castleman's disease: prospects for the next decade, (Tomohiro.Koga), Shino.Fujimoto, Astushi.Kawakami, Hiroshi.Kawabata, Yasufumi.Masaki, Tadamitsu.Kishimoto and Kazuyuki.Yoshizaki, EXPERT OPINION ON ORPHAN DRUGS, 5:633-640, 2017
• Dose-abjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase Ⅱ trial of West-JHOG PTCL0707, (Yoshinobu.Maeda), Hisakazu.Nishimori, Isao.Yoshida, Hasushi.Hiramatsu, Masatosh.Uno, Yasufumi.Masaki, Kazutaka.Sunami, Taro.Masunari, Yuichiro.Nawa, Hiromichi.Yamane, Hiroshi.Gomyo, Tsutomu.Takahashi, Tomofumi.Yano, Keitaro.Matsuo, Koichi.Ohshima, Shigeo.Nakamura, Tadashi.Yoshino, and Mitsune Tanimoto, Haematologica, 102:2097-2103, Dec. 2017
• A host-dependent prognostic model for elderly patients with diffuse large B-cell lymphoma, (Katsuhiro.Miura), Jun.Konishi, Takaaki.Miyake, Masanori.Makita, Atsuko.Hojo, Yasufumi.Masaki, Masatoshi.Uno, Jun.Ozaki, Chikamasa.Yoshida, Daigo.Niiya, Koichi.Kitazume, Yoshinobu.Maeda, Jun.Takizawa, Rika.Sakai, Tomofumi.Yano, Kazuhiko.Yamamoto, Kazutaka.Sunami, Yasushi.Hiramatsu, Kazutoshi.Aoyama, Hideki.Tsujimura, Jun.Murakami, Yoshihiro.Hatta, Masatoshi.Kanno, The Oncologist, 22:554-560, May 2017
• Long-term heat exposure prevents hypoxia-induced apoptosis in mouse fibroblast cells, (N.Sugimoto), O.Shido, K.Matsuzaki, M.Katakura, Y.Hitomi, M.Tanaka, T.Sawaki, Y.Fujita, T.Kawanami, Y.Masaki, T.Okazaki, H.Nakamura, S.Koizumi, A.Yachie, H.Umehara, Cell biochemistry and biophysics., 70:301-307, Sep. 2014
• Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Faslpr mice, Y.Fujita, T.Fujii, T.Mimori, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, Journal of immunology (Baltimore, Md. : 1950), 192:979-984, 2014
• Red cell transfusion in home, (Junithci.Kitazawa), Yoshiko.Tamai, Hiroshi.Fujita, Shigeyoshi.Makino, Yasufumi.Masaki, Eijiro.Omoto, Hidetaka.Oda, Hiroshi.Nakamura, Toshihiko.Futagi, Yuu.Kuroda, Naoki.Tachibana, Masanori.Matsumoto, and Tadashi.Matsushita, Japanese Journal of Transfusion and Cell Therapy, 63:664-773, 2017
• Proposed diagnostic criteria, disease severity classification, and treatment strategy for a novel disorder; TAFRO syndrome., Y.Masaki, H.Kawabata, K.Takai, N.Tsukamoto, S.Fujimoto, Y.Ishigaki, N.Kurose, M.Kojima, S.Nakamura, T.Kinoshita, S.Aoki, [Rinshō ketsueki] The Japanese journal of clinical hematology, 57:2029-2037, 2016
• How to diagnose and treat IgG4-related disease, Y.Masaki, S.Fujimoto, H.Kawanami(Iwao), T.Sakai, T.Kawanami, Y.Fujita, H.Kawabata, T.Fukushima, Journal of Kanazawa Medical University, 41:67-72, Dec. 2016
• Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version., Y.Masaki, H.Kawabata, K.Takai, M.Kojima, N.Tsukamoto, Y.Ishigaki , N.Kurose, M.Ide, J.Murakami, K.Nara, H.Yamamoto, Y.Ozawa, H.Takahashi, K.Miura, T.Miyauchi, S.Yoshida, A.Momoi, N.Awano, S.Ikushima, Y.Ohta, N.Furuta, S.Fujimoto, H.Kawanami, T.Sakai, T.Kawanami, Y.Fujita, T.Fukushima, S.Nakamura, T.Kinoshita, S.Aoki, International journal of hematology, 103:686-692, 2016
  DOI:10.1007/s12185-016-1979-1
• Isolation of vascular smooth muscle antigen-reactive CD4(+)αβTh1 clones that induce pulmonary vasculitis in MRL/Mp-Fas(+/+) mice., Y.Fujita, T.Fujii, H.Shimizu, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, T.Mimori, Cellular immunology, 303:50-54, 2016
  DOI:10.1016/j.cellimm.2016.03.004
• Proposed diagnostic criteria, disease severity classification, and tretment strategy for a novel disorder;TAFRO syndrome, Y.Masaki, H.Kawabata, K.Takai, N.Tsukamoto, S.Fujimoto, Y.Ishigaki, N.Kurose, M.Kojima, S.Nakamura, T.Kinoshita, S.Aoki, Japanese TAFRO syndrome research team, 57:195-203, Oct. 2016
• IgG4-Related Disease: Diagnostic Methods and Therapeutic Strategies in Japan, Masaki Yasufumi;Shimizu Hironori;Sato Nakamura Tomomi;Nakamura Takuji;Nakajima Akio;Iwao Kawanami Haruka;Miki Miyuki;Sakai Tomoyuki;Kawanami Takafumi;Fujita Yoshimasa;Tanaka Masao;Fukushima Toshihiro, The journal of the Japanese Society of Lymphoreticular Tissue research, 54:95-101, 2014
• Diagnosis and treatment of IgG4-related disease-Including IgG4-related skin disease-, Y.Masaki, H.Shimizu, T.Nakamura(Satoh), T.Nakamura, A.Nakajima, H.Kawanami(Iwao), T.Kawanami, K.Yamada, Y.Hamaguchi, M.Kawano, Y.Fujita, T.Fukushima, Journal of Environmental Dermatology and Cutaneous Allergology, 9:212-217, Oct. 2015
• International consensus guidance statedment on the management and treatment of IgG4-related disease, (A.Khosroshahi), Z.S.Wallace, J.L.Crowe, T.Akamizu, A.Azumi, M.N.Carruthers, S.T.Chari, E.Della-Torre, L.Frulloni, H.Goto, P.A.Hart, T.Kamisawa, S.Kawa, M.Kawano, M.H.Kim, Y.Kodama, K.Kubota, M.M.Lerch, M.Löhr, Y.Masaki, S.Matsui, T.Mimori, S.Nakamura, T.Nakazawa, H.Ohara, K.Okazaki, T.H.Ryu, T.Saeki, N.Schleinitz, A.Shimatsu, T.Shimosegawa, H.Takahashi, M.Takahira, A.Tanaka, M.Topazian, H.Umehara, G.J.Webster, T.E.Witzing, M.Yamamoto, W.Zhang, T.Chiba, J.H.Stone, Arthritis & Rheumatology, 67:1688-1699, Jul. 2015
• Decreased expression of innate immunity-related genes in peripheral blood mononuclear cells from patients with IgG4-related disease, A.Nakajima, Y.Masaki, T.Nakamura, T.Kanawami, Y.Ishigaki, T.Takegami, M.Kawano, K.Yamada, N.Tsukamoto, S.Matsui, T.Saeki, K.Okazaki, T.Kamisawa, T.Miyashita, Y.Yakushijin, K.Fujikawa, M.Yamamoto, H.Hamano, T.Origuchi, S.Hirata, H.Tsuboi, T.Sumida, H.Morimoto, T.Sato, H.Iwao, M.Miki, T.Sakai, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, PLoS One, 10:e0126582-e0126582, May 2015
  DOI:10.1371/journal.pone.0126582
• CD14+ follicular dendritic cells in lymphoid follicles may play a role in the pathogenesis of IgG4-related disease, T.Satoh-Nakamura, N.Kurose, T.Kawanami, T.Nakamura, H.Iwao-Kawanami, A.Nakajima, M.Miki, T.Sakai, Y.Fujita, M.Tanaka, T.Fukushima, Y.Masaki, Biomedical Research, 36:143-153, Feb. 2015
• Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group, T.Sakai, Y.Masaki, N.Otsuki, I.Sakamaki, S.Kishi, T.Miyazono, Y.Urasaki, J.Murakami, T.Satoh, T.Nakamura, H.Iwao, A.Nakajima, T.Kawanami, M.Miki, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, T.Ueda, Medical Oncology, 32:232-238, 2015
• A case of probable IgG4-related disease involving the unilateral trigeminal nerve of the cheek region, (H.Yohida), N.Yasuda, T.Hayashi, K.Tujii, M.Wato, S.Gamoh, K.Shimizutani, A.Tanaka, Y.Masaki, S.Morita, Oral Radiology, 31:193-198, 2015
• Long-term heat exposure prevents hypoxia-induced apoptosis in mouse fibroblast cells, (N.Sugimoto), O.Shido, K.Matsuzaki, M.Katakura, Y.Hitomi, M.Tanaka, T.Sawaki, Y.Fujita, T.Kawanami, Y.Masaki, T.Okazaki, H.Nakamura, S.Koizumi, A.Yachie, H.Umehara, Cell biochemistry and biophysics., 70:301-307, Sep. 2014
• IgG4-related disease:Diagnostic methods and therapeutic strategies in Japan, Y.Masaki, H.Shimizu, T.Sato, T.Nakamura, A.Nakajima, H.Iwao, M.Miki, T.Sakai, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, Journal of clinical and experimental hematopathology : JCEH., 54:95-101, 2014
• Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Faslpr mice, Y.Fujita, T.Fujii, T.Mimori, T.Sato, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Kawanami, M.Tanaka, Y.Masaki, T.Fukushima, T.Okazaki, H.Umehara, Journal of immunology (Baltimore, Md. : 1950), 192:979-984, 2014
• Clinical course after corticosteroid therapy in IgG4-related aortitis/preiaortitis and periarteritis: a retrospective multicenter study, (I.Mizushima), D.Inoue, M.Yamamto, K.Yamada, T.Saeki, Y.Ubara, S.Matsui, Y.Masaki, T.Wada, S.Kasashima, K.Harada, H.Takahashi, K.Notohara, Y.Nakamura, H.Umehara, M.Yamagishi, M.Kawano, Arthritis research & therapy., 16:R156;1-11, 2014
• Japanese variant of multicentirc castleman's disease associated with serositis and thrombocytopenia-a report of two cases: Is TAFRO syndrome(Castleman-Kojima Disease) a distinct clinicopathological entity?, Y.Masaki, A.Nakajima, H.Iwao, N.Kurose, T.Sato, T.Nakamura, M.Miki, T.Sakai, T.Kawanami, T.Sawaki, Y.Fujita, M.Tanaka, T.Fukushima, T.Okazaki, H.Umehara, Journal of clinical and experimental hematopathology : JCEH., 53:79-85, Jun. 2013
• Castleman-Kojima disease(TAFRO Syndrome): A novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites(Anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: A status report and summary of Fukushima(6 June, 2012) and Nagoya meetings(22 September, 2012), (H.Kawabata), K.Takai, M.Kojima, N.Nakamura, S.Aoki, S.Nakamura, T.Kinoshita, Y.Masaki, Journal of clinical and experimental hematopathology : JCEH., 53:57-61, Jun. 2013
• Upregulation of aquaporin expression in the salivary glands of heat-acclimated rats., (N.Sugimoto), K.Matsuzaki, H.Ishibashi, M.Tanaka, T.Sawaki, Y.Fujita, T.Kawanami, Y.Masaki, T.Okazaki, J.Sekine, S.Koizumi, A.Yachie, H.Umehara, O.Shido, Scientific reports, 3:1763;1-8, 2013
• Possible mechanisms of lymphoma development in Sjoguren's syndrome., (L.Dong), Y.Chen, Y.Masaki, T.Okazaki, H.Umehara, Current immunology reviews, 9:13-22, 2013
• Consensus statement on the pathology of IgG4-related disease, (V.Deshpande), Y.Zen, J.Chan, E.Yi, Y.Sato, T.Yoshino, G.Kloppel, J.G.Heathcote, A.Khosroshahi, J.A.Ferry, R.C.Aalberse, D.B.Bloch, W.R.Brugge, A.C.Bateman, M.N.Carruthers, S.T.Chari, W.Cheuk, L.D.Cornell, C.FD.Castillo, D.G.Forcione, D.L.Hamilos, T.Kamisawa, S.Kasashima, S.Kawa, M.Kawano, G.Y.Lauwers, Y.Masaki, Y.Nakamura, K.Notohara, K.Okazaki, J.K.Ryu, T.Saeki, D.V.Sahani, T.C.Smyrk, J.R.Stone, M.Takahira, G.J.Webster, M.Yamamoto, G.Zamboni, H.Umehara, J.H.Stone, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc., 25:1181-1192, Sep. 2012
• Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era, (N.Tomita), M.Yokoyama, W.Yamamoto, R.Watanabe, Y.Shimazu, Y.Masaki, S.Tsunoda, C.Hashimoto, K.Murayama, T.Yano, R.Okamoto, A.Kikuchi, K.Tamura, K.Sato, K.Sunami, H.Shibayama, R.Takimoto, R.Ohshima, Y.Hatta, Y.Moriuchi, T.Kinoshita, M.Yamamoto, A.Numata, Y.Ishigatsubo, K.Takeuchi, Cancer science., 103:245-251, Feb. 2012
• A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details, H.Umehara, K.Okazaki, Y.Masaki, M.Kawano, M.Yamamoto, T.Saeki, S.Matsui, T.Sumida, T.Mimori, Y.Tanaka, K.Tsubota, T.Yoshino, S.Kawa, R.Suzuki, T.Takegami, N.Tomosugi, N.Kurose, Y.Ishigaki, A.Azumi, M.Kojima, S.Nakamura, D.Inoue, Modern rheumatology / the Japan Rheumatism Association., 22:1-14, 2012
• Efficacy and safety of bortezomib plus dexamethasone therapy for refractory or relapsed multiple myeloma: once-weekly administration of bortezomib may reduce the incidence of gastrointestinal adverse events, T.Fukushima, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sato, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, H.Nakajima, Y.Motoo, H.Umehara, Anticancer research., 31:2297-2302, Sep. 2011
• IgG4-related Mikulicz's disease and Sjogren's syndrome, Y.Masaki, T.Nakamura, H.Iwao, A.Nakajima, H.Umehara, 55:763-769, Aug. 2011
• Intravascular large B-cell lymphoma: an important cause of fever of unknown origin, Y.Masaki, M.Miki, T.Sakai, T.Sawaki, T.Fukushima, H.Umehara, 63:435-441, May 2011
• Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia, T.Fukushima, H.Kawabata, T.Nakamura, H.Iwao, A.Nakajima, M.Miki, T.Sakai, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, Y.Hirose, H.Umehara, Anticancer research., 31:1741-1744, May 2011
• IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century, Y.Masaki, N.Kurose, H.Umehara, Journal of clinical and experimental hematopathology : JCEH., 51:13-20, 2011
• IgG4-related disease (IgG4+MOLPS)-diagnostic criteria and diagnostic problems, Y.Masaki, H.Iwao, A.Nakajima, M.Miki, S.Sugai, H.Umehara, Current immunology reviews, 7:172-177, 2011
• High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma, Y.Masaki, M.Miki, Y.Sun, T.Nakamura, H.Iwao, A.Nakajima, N.Kurose, T.Sakai, Z.Jin, T.Sawaki, T.Kawanami, Y.Fujita, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, International journal of hematology., 93:720-726, 2011
• Does more intensive therapy have effects on mantle cell lymphoma? A clinical experience from the lymphoma treatment study group in Japan, (K.Miura), H.Takasaki, H.Tsujimura, M.Kanno, Y.Maeda, N.Tomita, K.Takai, Y.Masaki, J.Takizawa, H.Mori, Y.Terasaki, T.Yoshida, J.Takeuchi, S.Motomura, International journal of hematology., 93:684-686, 2011
• Primary neurolymphomatosis of the cervical nerve root, M.miki, Y.Masaki, T.Nakamura, H.Iwao, A.Nakajima, T.Sakai, T.Sawaki, T.Kawanami, M.Kaito, N.Kurose, Y.Fujita, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, 51:564-567, Jul. 2010
• Complete response obtained by bortezomib plus dexamethasone in a patient with relapsed multiple myeloma with multiple plasmacytomas, T.Fukushima, T.Nakamura, M.Miki, T.Sakai, H.Iwao, A.Nakajima, T.Sawaki, Y.Fujita, M.Tanaka, Y.Masaki, Y.Hirose, H.Umehara, Anticancer research., 30:3791-3794, Jun. 2010
• Palliative radiotherapy with 1 x 8 Gy using conformal radiotherapy for chemotherapy-refractory, recurrent, aggressive lymphomas, M.Matoba, K.Oota, H.Tonami, Y.Masaki, T.Sakai, H.Umehara, Japanese journal of radiology, 28:220-223, May 2010
• IgG4-related disease:historical overview and pathology of hematological disorders, (Y.Sato), K.Notohara, M.Kojima, K.Takata, Y.Masaki, T.Yoshino, Pathology International, 60:247-258, Apr. 2010
• Synergistic effects of topoisomerase I inhibitor, SN38, on Fas-mediated apoptosis, Y.Cao, Z.Jin, X.Tong, S.Yue, T.Sakai, T.Kawanami, T.Sawaki, M.Miki, H.Iwao, A.Nakajima, Y.Masaki, Y.Fukushima, Y.Fujita, H.Nakajima, T.Okazaki, H.Umehara, Anticancer research., 30:3911-3918, 2010
• DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistaitin-like 1 - analysis of their binding with TGF-β superfamily proteins, M.Tanaka, K.Murakami, S.Ozaki, Y.Imura, X.Tong, T.Watanabe, T.Sawaki, T.Kawanami, D.Kawabata, T.Fujii, T.Usui, Y.Masaki, T.Fukushima, Z.Jin, H.Umehara, T.Mimori, The FEBS journal, 277:4278-4289, 2010
• Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis, (T.Saeki), S.Nishi, N.Imai, T.Ito, H.Yamazaki, M.Kawano, M.Yamamoto, H.Takahashi, S.Matsui, S.Nakada, T.Origuchi, A.Hirabayashi, N.Homma, Y.Tsubata, T.Takata, Y.Wada, A.Saito, S.Fukase, K.Ishioka, K.Miyazaki, Y.Masaki, H.Umehara, S.Sugai, I.Narita, Kidney international., 78:1016-1023, 2010
• Cisplatin augments FAS-mediated apoptosis through lipid rafts, C.Huang, Z.Jin, L.Dong, X.Tong, S.Yue, T.Kawanami, T.Sawaki, T.Sakai, M.Miki, H.Iwao, A.Nakajima, Y.Masaki, Y.Fukushima, M.Tanaka, Y.Fujita, H.Nakajima, T.Okazaki, H.Umehara, Anticancer research., 30:2065-2072, 2010
• Very Good Partial Response and Long Time to Progression by Short-Term Bortezomib Plus Dexamethasone Therapy for a Patient with Relapsed and Refractory Multiple Myeloma―A Case Report, 36:1387-1389, Aug. 2009
• MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy, T.Fukushima, H.Iwao, A.Nakazima, M.Miki, T.Sakai, T.Sawaki, M.Tanaka, Y.Masaki, Y.Hirose, H.Umehara, Anticancer research., 29:3361-3364, Aug. 2009
• Huge malignant lymphoma of the thyroid gland complicated by recurrent esophageal and tracheal fistulas induced by chemotherapy, A.Sakai, Y.Shimode, H.Tsuji, Y.Masaki, 34:72-76, Aug. 2009
• Complete resection of an advanced mediastinal nonseminomatous germ cell tumor with multiple distant metastases after Douwn-staging by chemotherapy, K.Usuda, M.Sagawa, H.Aikawa, M.Ueno, M.Tanaka, Y.Machida, K.Tsuchihara, Y.Masaki, E.Kinoshita, T.Sakuma, 62:545-551, Jul. 2009
• Proposal for a new clinical entity,IgG4-positive multiorgan lymphoproliferative syndrome:analysis of 64 cases of IgG4-related disorders, Y.Masaki, L.Dong, N.Kurose, K.Kitagawa, Y.Morikawa, M.Yamamoto, H.Takahashi, Y.Shinomura, K.Imai, T.Saeki, A.Azumi, S.Nakada, E.Sugiyama, S.Matsui, T.Origuchi, S.Nishiyama, I.Nishimori, T.Nojima, K.Yamada, M.Kawano, Y.Zen, M.Kaneko, K.Miyazaki, K.Tsubota, K.Eguchi, K.Tomoda, T.Sawaki, T.Kawanami, M.Tanaka, T.Fukushima, S.Sugai, H.Umehara, Annals of the rheumatic diseases., 68:1310-1315, 2009
• Successful rituximab monotherapy for API2-MALT1 fusion posotive primary mucosa-associated lymphoid tissue lymphoma of the transverse colon in a patient with liver cirrhosis, M.Yamada, H.Kawahara, H.Shiroeda, M.Tsuchishima, Y.Masaki, K.Sato, S.Takase, Scandinavian journal of gastroenterology, 43:761-764, Jun. 2008
• Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody(rituximab)in a patient with systemic lupus erythematosus, T.Fukushima, L.Dong, T.Sakai, T.Sawaki, M.Miki, M.Tanaka, Y.Masaki, Y.Hirose, M.Kuwana, H.Umehara, Lupus, 17:210-214, Mar. 2008
• Investigation of usefulness of drugs prescribed for supportive therapy for CHOP-related chemotherapy based on clinical pathway, Y.Saito, K.Naruhashi, N.Inoue, A.Kubo, Y.Takahashi, M.Kobori, Y.masaki, K.Nishio, 34:52-58, 2008
• Impaired TCR signaling through dysfunction of lipidrafts in sphingomyelin synthase 1(SMS1)-knockdown T cells, Z.Jin, C.Huang, L.Dong, S.Goda, T.Kawanami, T.Sawaki, T.Sakai, X.Tong, Y.Masaki, T.Fukushima, M.Tanaka, T.Mimori, H.Tojo, E.Bloom, T.Okazaki, H.Umehara, International immunology., 20:1427-1437, 2008
• Current and prospective treatment options for Sjogren's syndrome, (S.Sugai), Y.Masaki, Expert Review of Clinical Immunology, 4:469-479, 2008
• Analysis of clinical significance of anti-cyclic citrullinated peptide antibody (anti-CCP antibody) in rheumatoid arthritis(RA)., (K.Shimoyama), N.Ogawa, T.Sakai, T.Sawaki, T.Kawanami, H.Karasawa, Y.Masaki, M.Tanaka, T.Fukushima, Y.Hirose, H.Umehara, 30:408-413, Oct. 2007
• Identification of human salivary stem cells from cultured labial minor salivary cells, T.Kawanami, Y.Matsuzaki, T.Sawaki, T.Sakai, Z.Jin, Y.Masaki, T.Fukushima, M.Tanaka, H.Umehara, 30:455-460, 2007
• Urinary pseudouridine in patients with lymphoma:Comparison with other clinical parameters, Y.Masaki, K.Itoh, T.Sawaki, H.Karasawa, T.Kawanami, T.Fukushima, H.Kawabata, Y.Wano, Y.Hirose, T.Suzuki, S.Sugai, H.Umehara, Clinica chimica acta; international journal of clinical chemistry., 371:148-151, 2006
• Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8, (H.Kawabata), T.Sawaki, T.Kawanami, K.Shimoyama, H.Karasawa, T.Fukushima, Y.Masaki, N.Ogawa, Y.Hirose, K.Ozaki, K.Shimanaka, S.Takase, H.Ueno, H.Umehara, Internal medicine (Tokyo, Japan), 45:1309-1314, 2006
• Fractalkine in rheumatoid arthritis and allied conditions, H.Umehara, M.Tanaka, T.Sawaki, Z.X.Jin, C.R.Huang, L.Dong, T.Kawanami, H.Karasawa, Y.Masaki, T.Fukushima, Y.Hirose, T.Okazaki, Modern rheumatology / the Japan Rheumatism Association., 16:124-130, 2006
• Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan, Y.Hirose, Y.Masaki, T.Sawaki, K.Shimoyama, H.Karasawa, H.Kawabata, T.Fukushima, N.Ogawa, Y.Wano, H.Umehara, European journal of haematology., 76:109-118, 2006
• A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid, K.Shimoyama, N.Ogawa, T.Sawaki, H.Karasawa, Y.Masaki, H.Kawabata, T.Fukushima, Y.Wano, Y.Hirose, H.Umehara, Modern rheumatology / the Japan Rheumatism Association., 16:176-182, 2006
• Sjogren's syndrome, H.Umehara, T.Sawaki, T.Kawanami, Y.Masaki, T.Fukushima, 67:511-516, May 2005
• Cloning and expression of a novel human antibody-antigen pair assosciated with Felty's syndrome, MASAKI Yasufumi, PNAS, 2000
• Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma, (Katsuhiro Miura), Hideki Tsujimura, Yasufumi Masaki, Masaki Iino, Jun Takizawa, Yoshinobu Maeda, Kazuhiko Yamamoto, Shinobu Tamura, Akiyo Yoshida, Hideo Yagi, Isao Yoshida, Koichi Kitazume, Taro Masunari, Ileung Choi, Yasutaka Kakinoki, Ritsuro Suzuki, Tadashi Yoshino, Shigeo Nakamura, Yoshihiro Hatta, Takashi Yoshida, Masatoshi Kanno, Hematological Oncology, 39:51-59, Jan. 2021
• A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial, (Ken Ohmachi), Tomohiro Kinoshita, Gakuto Ogawa, Tomonori Mizutani, Nobuhiko Yamauchi, Noriko Fukuhara, Toshiki Uchida, Kazuhito Yamamoto, Kana Miyazaki, Norifumi Tsukamoto, Shinsuke Iida, Takahiko Utsumi, Isao Yoshida, Yoshitaka Imaizumi, Takashi Tokunaga, Shinichiro Yoshida, Yasufumi Masaki, Tohru Murayama, Yoshihiko Yakushijin, Youko Suehiro, Kisato Nosaka, Nobuaki Dobashi, Junya Kuroda, Yasushi Takamatsu, Dai Maruyama, Kiyoshi Ando, Kenichi Ishizawa, Michinori Ogura, Tadashi Yoshino, Tomomitsu Hotta, Kunihiro Tsukasaki, Hirokazu Nagai, and the Japan Clinical Oncology Group, blood advances, 5:984-993, 2021
• Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease, (Sheila K. Pierson), Sushila Shenoy, Ana B. Oromendia, Alexander M. Gorzewski, Ruth-Anne Langan Pai, Christopher Shield Nabal, Jason R. Ruth, Sophia A.T. Parente, Daniel J. Arenas, Mary Guilfoye, Manjula Reddy, Michael Weinblatt, Nancy Shadick, Mark Bower, Alessia Dalla Pria, Yasufumi Masaki, Laura Katz, Jason Mezey, Philip Beineke, David Lee, Craig Tendler, Taku Kambayashi, Alexander Fossa, Frits van Rhee, and Davied C. Faigenbaum, blood advances, 5:3445-3456, 2021
• Patient's age and D-dimer levels predict the prognosis in patients with TAFRO syndrome, Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Hiroto Yanagisawa, Toshio Kitawaki, Kenji Nara, Masao Hagihara, Hiroshi Yamamoto, Masakuni Tanimizu, Chikako Kato, Tomoki Origuchi, Kazutaka Sunami, Yoshitaka Sunami, Taro Masunari, Nobuhiko Nakamura, Masanori Kobayashi, Keiko Yamagami, Katsuhiro Miura, Kazue Takai, Sadao Aoki, Norifumi Tsukamoto, Yasufumi Masaki, International Journal of Hematology, 114:179-188, 2021
• Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma, (Kazuyuki Shimada), Kenichi Yoshida, Yasuhiro Suzuki, Chisako Iriyama, Yoshikage Inoue, Masashi Sanada, Keisuke Kataoka, Masaki Yuge, Yusuke Takagi, Shigeru Kusumoto, Yasufumi Masaki, Takahiko Ito, Yuichiro Inagaki, Akinao Okamoto, Yachiyo Kuwatsuka, Masahiro Nakatochi, Satoko Shimada, Hiroaki Miyoshi, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Yusuke Shiozawa, Yasuhito Nannya, Asako Okabe, Kei Kohno, Yoshiko Atsuta, Koichi Ohshima, Shigeo Nakamura, Seishi Ogawa, Akihiro Tomita, and Hitoshi Kiyoi, blood, 137:1491-1502, 2021
• Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan, Shino Fujimoto, Hiroshi Kawabata, Tomoyuki Sakai, Hiroto Yanagisawa, Momoko Nishikori, Kenji Nara, Shin Ohara Norifumi Tsukamoto, Nozomu Kurose, Sohsuke Yamada, Kazue Takai, Sadao Aoki, Yasufumi Masaki, International Journal of Hematology, 113:73-80, 2021
• Comprehensive analysis of protein-expression changes specific to immunoglobulin G4-related disease, Takafumi Kawanami, Haruka Kawanami-Iwao, Takanobu Takata, Yasuhito Ishigaki, Naohisa Tomosugi, Tsutomu Takegami, Hiroto Yanagisawa, Shino Fujimoto, Tomoyuki Sakai, Yoshimasa Fujita, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Yuko Hirose, Yasufumi Masaki, Clinica Chimica Acta, 523:45-57, 2021
• Faggot cells in acute myeloid leukemia with t(7;11)(p15;p15) and NUP98-HOXA9 fusion, Hiroto Yanagisawa, Shuichi Mizuta, Hiroshi Kawabata, Shino Fujimoto, Tomoyuki Sakai, Haruka Iwao-Kawanami, Takafumi Kawanami, Kazunori Yamada, Toshihiro Fukushima, Katsunori Kyoda, Yasufumi Masaki, Annals of Hematology, 100:2121-2123, Aug. 2021
• Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma, (Kana Miyazaki), Ritsuro Suzuki, Masahiko Oguchi, Senzo Taguchi, Jun Amaki, Takeshi Maeda, Nobuko Kubota, Dai Maruyama, Yasuhito Terui, Nodoka Sekiguchi, Jun Takizawa, Hiroyuki Tsukamoto, Tohru Murayama, Toshihiko Ando, Hiroshi Matsuoka, Masatoshi Hasegawa, Hideho Wada, Rika Sakai, Yoshihiro Kameda, Norifumi Tsukamoto, Ilseung Choi, Yasufumi Masaki, Kazuyuki Shimada, Noriko Fukuhara, Takahiko Utsumi, Nobuhiko Uoshima, Yoshitoyo Kagami, Naoko Asano, Yasuo Ejima, Maoyuki Katayama, Motoko Yamaguchi, Hematological Oncology, 40:667-677, 2022
• An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma, (Momoko Nishikori), Yasufumi Masaki, Nobuharu Fujii, Takashi Ikeda, Mariko Takahara-Matsubara, Saori Sugimoto, Eisei Kondo, International Journal of Hematology, 115:391-398, 2022
• Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes, Hiroto Yanagisawa, Hiroshi Kawabata, Yusuke Ueda, Kotaro Arita, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, International Journal of Hematology, 116:81-88, 2022
• Castleman disease and TAFRO syndrome, Yasufumi Masaki, Kotaro Arita, Tomoyuki Sakai, Kazue Takai, Sadao Aoki, Hiroshi Kawabata, Annals of Hematology, 101:485-490, 2022
• Abnormal exacerbation of moderately differentiated gastric adenocarcinoma in a patient with TAFRO syndrome: An impaired tumor immunity?, (Tadaaki Inano), Hajime Yasuda, Yutaka Tsukune, Miyuki Tsutsui, Nadila Wali, Harumi Saeki, Kazunori Kajino, Okio Hino, Yasufumi Masaki, Norio Komatsu, Case Reports in Oncology, 15:7-11, 2022
• TAFRO syndrome: A disease requiring immediate medical attention, Yasufumi Masaki, Yusuke Ueda, Hiroto Yanagisawa, Kotaro Arita, Tomoyuki Sakai, Kazunori Yamada, Shuichi Mizuta, Toshihiro Fukushima, Kazue Takai, Sadao Aoki, and Hiroshi Kawabawa, Internal Medicien, 62:27-32, Jan. 2023
• Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of MYD88 L265P mutation in cerebrospinal fluid of primary CNS lymohoma patients, (Haruhiko Takahashi), Manabu Matsumeda, Jotaro On, Jun Watanabe, Mari Tada, Hiroshi Shimizu, Yoshihiro Tsukamoto, Masayasu Okada, Makoto Oishi, Jun Takizawa, Yasuhiko Hayashi, Yasufumi Masaki, Akiyoshi Kakita, Yukihiko Fujii, Leukemia & Lymohoma, 64:1219-1222, Apr. 2023
• Five-year follow-up of a phase Ⅱ study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL, (Kana Miyazaki), Rika Sakai, Noriko Iwaki, Go Yamamoto, Kayoko Murayama, Momoko Nishikori, Kazutaka Sunami, Isao Yoshida, Hiroki Yano, Naoki Takahashi, Akinao Okamoto, Saori Munemoto, Aiko Sawazaki, Youko Suehiro, Noriko Fukuhara, Atsushi Wake, Ayako Arai, Yasufumi Masaki, Kohtaro Toyama, Akihiro Yokoyama, Hiroko Tsunemine, Yuichi Hasegawa, Kenji Matsumoto, Tomomi Yamada, Yuki Nishimura, Satoshi Tamaru, Naoko Asano, Kohta Miyawaki, Koji Izutsu, Tomohiro Kinoshita, Ritsuro Suzuki, Koichi Ohshima, Koji Kato, Naoyuki Katayama, Motoko Yamaguchi, Cancer Science, 114:2689-2691, Jun. 2023
• Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study, (Hiroshi Funaki), Naomi Nojima, Yutaka Takikawa, Kazutoshi Komori, Hajime Hasegawa, Tomoyuki Sakai, Sohsuke Yamada, and Yasufumi Masaki, Surgical Case Reports, 9:103, Jun. 2023
• Primary Effusion Lymphoma-like ATL Developing during Hemodialysis, Miharu Masaki, Yuki Okushi, Atsushi Saito, Akihiro Fukuda, Sohsuke Yamada, Shuichi Mizuta, Yasufumi Masaki, Internal Medicine, 62:1807-1811, Jun. 2023
  DOI:DOI: 10.2169/internalmedicine.9745-22
• Prospective therapeutic studies of disseminated extranodal large B-cell lymphoma including intravascular large B-cell lymphoma, Tomoyuki Sakai, Yusuke Ueda, Hiroto Yanagisawa, Kotaro Arita, Haruka Iwao, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Katsunori Tai, Shinji Kishi, Koji Morinaga, Jun Murakami, Hiroyuki Takamatsu, Yasushi Terasaki, Nobuyuki Yoshio, Yukio Kondo, Hirokazu Okumura, Sadaya Matano, Masaki Yamaguchi, Hiroshi Tsutani, Yasufumi Masaki, Global Health & Medicine, 6:277-281, Aug. 2024
• Fatal hemophagocytic lymphohistiocytosis with intravascular large B-cell lymphoma following coronavirus disease 2019 vaccination in a patient with systemic lupus erythematosus: an intertwined case, Yusuke Ueda, Tomoyuki Sakai, Kazunori Yamada, Kotaro Arita, Yoko Ishige, Daisuke Hoshi, Hiroto Yanagisawa, Haruka Iwao-Kawanami, Takafumi Kawanami, Shuichi Mizuta, Toshihiro Fukushima, Sohsuke Yamada, Akihiro Yachie, Yasufumi Masaki, Immunological Medicine, 47:192-199, Sep. 2024
  DOI:DOI: 10.1080/25785826.2024.2338594
• Dynamics of serum cytokines and chemokines in patients with idiopathic multicentric Castleman Disease: From a phase Ib Investigator-Initiated trial of filgotinib, Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita, Shimpei Morimoto, Hiroshi Yano, Atsushi Katsube, Shingo Yano, Yasufumi Masaki, Shinichiro Tsunoda, Shuzo Sato, Kiyoshi Migita, Atsushi Kawakami, Cureus, 17:e78974, 2025
• A phase Ib investigator-initiated trial of filgotinib in patients with idiopathic multicentric Castleman Disease, Shoichi Fukui, Remi Sumiyoshi, Tomohiro Koga, Naoki Hosogaya, Sawana Narita, Shimpei Morimoto, Hiroshi Yano, Atsushi Katsube, Shingo Yano, Yasufumi Masaki, Shinichiro Tsunoda, Shuzo Sato, Kiyoshi Migita, Kazuko Matsuyama, Naoki Kato, Atsuhiko Kawamoto, Atsushi Kawakami, Cureus, 17:e78865, 2025
• IgG4-related disease concomitant with diffuse large B-cell lymphoma, Hiroto Yanagisawa, Keita Mishima, Yaya Yamanouchi, Yusuke Ueda, Takahiro Yamano, Haruka Iwao-Kawanami, Tomoyuki Sakai, Takafumi Kawanami, Kazunori Yamada, Mitsuhiro Kawano, Shuichi Mizuta, Toshihiro Fukushima, Yasufumi Masaki, 64:953-957, 2025
• Treatments and outcomes of newly diagnosed CD5-positive diffuse large B-cell lymphoma: a multi-institutional observational Study, Yuma Nato, Kana Miyazaki, Dai Maruyama, Hiroyuki Takahashi, Kazutaka Sunami, Satsuki Murakami, Eiju Negoro, Yuri Miyazawa, Ilseung Choi, Takahiro Okada, Nobuyuki Takayama, Naoto Tomita, Shuji Momose, Yuto Kaneda, Masahiro Yoshida Hiroshi Gomyo, Kohtaro Tayama, Momoko Nishikori, Akio Saito, Junji Hiraga, Taro Masunari, Naoki Takahashi, Junya Makiyama, Tomotaka Suzuki, Hiroko Tsunemine, Jun Takizawa, Takeharu Kato, Yasufumi Masaki, Noriko Fukuhara, Masataka Okamoto, Isao Tawara, Naoko Asano, Koichi Ohshima, Koji Izutsu, Ritsuro Suzuki, Motoko Yamaguchi, 43:e70047, 2025
• Exploring the clinical diversity of Castleman disease and TAFRO syndorome: A Japanese muliticenter study on lymph node distribution patterns, Mizuna Otsuka, Tomohiro Koga, Remi Sumiyoshi, Shoichi Fukui, Yuko Kaneko, Takayuki Shimizu, Atsushi Katsube, Shingo Yano, Yasufumi Masaki, Makoto Ide, Hajime Yoshifuji, Masayasu Kitano, Yasuharu Sato, Naoki Sawa, Hiroaki Niiro, Naoya Nakamura, David C Fajgenbaum, Frits van Rhee, Atsuhi Kawakami, American Journal of Hematology, 100:592-605, 2025